Literature DB >> 19644673

Bacteraemia following single-stage percutaneous dilatational tracheostomy.

A G Saayman1, G P Findlay, R A Barnes, M P Wise.   

Abstract

OBJECTIVE: Surgical tracheostomy in critically ill adults has largely been replaced by physicians performing percutaneous dilatational tracheostomy (PDT) at the bedside. Complications associated with this technique include haemorrhage, wound infection, barotrauma, false passage, ruptured tracheal ring and bacteraemia. Prophylactic antibiotics are not generally used with this procedure, however the incidence of bacteraemia following PDT has not been extensively studied.
DESIGN: Prospective observational study.
SETTING: Adult intensive care unit of a university medical centre.
METHODS: Peripheral venous blood cultures were obtained immediately before and after PDT in 118 consecutive patients. Surveillance cultures of potential respiratory pathogens were also recorded using routine non-directed broncholalveolar lavage.
RESULTS: Forty-three female and 75 male patients underwent PDT. Fifty-seven patients (48.3%) were not receiving antibiotics on the day of PDT, whilst the remaining 61 individuals (51.7%) were on antibiotic therapy at the time of the procedure. Bacteraemia following PDT occurred in six out of 113 patients (5.3%), five of which occurred in patients not receiving antibiotics (9.2%). Unexpected bacteraemia (positive pre-and post PDT blood cultures) was identified in five patients, two of whom were on antibiotic therapy.
CONCLUSION: The incidence of bacteraemia following a single stage PDT was similar to other manipulations of the aerodigestive tract such as intubation, insertion of an LMA or tooth brushing. We suggest that routine antibiotic prophylaxis is unnecessary for this procedure.

Entities:  

Mesh:

Year:  2009        PMID: 19644673     DOI: 10.1007/s00134-009-1586-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

1.  The incidence of bacteraemia following laryngeal mask insertion.

Authors:  J Brimacombe; N Shorney; R Swainston; G Bapty
Journal:  Anaesth Intensive Care       Date:  1992-11       Impact factor: 1.669

2.  Prevalence, intensity and nature of bacteraemia after toothbrushing.

Authors:  Victoria S Lucas; Gavin Gafan; Sarah Dewhurst; Graham J Roberts
Journal:  J Dent       Date:  2008-05-02       Impact factor: 4.379

3.  Chlorhexidine compared with povidone-iodine as skin preparation before blood culture. A randomized, controlled trial.

Authors:  O Mimoz; A Karim; A Mercat; M Cosseron; B Falissard; F Parker; C Richard; K Samii; P Nordmann
Journal:  Ann Intern Med       Date:  1999-12-07       Impact factor: 25.391

4.  Device-associated nosocomial infections in 55 intensive care units of 8 developing countries.

Authors:  Victor D Rosenthal; Dennis G Maki; Reinaldo Salomao; Carlos Alvarez Moreno; Yatin Mehta; Francisco Higuera; Luis E Cuellar; Ozay Akan Arikan; Rédouane Abouqal; Hakan Leblebicioglu
Journal:  Ann Intern Med       Date:  2006-10-17       Impact factor: 25.391

5.  Incidence and risk factors of device-associated infections and associated mortality at the intensive care in the Dutch surveillance system.

Authors:  Tjallie I I van der Kooi; Annette S de Boer; Judith Manniën; Jan C Wille; Mariëlle T Beaumont; Ben W Mooi; Susan van den Hof
Journal:  Intensive Care Med       Date:  2006-12-05       Impact factor: 17.440

6.  A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination.

Authors:  J R Little; P R Murray; P S Traynor; E Spitznagel
Journal:  Am J Med       Date:  1999-08       Impact factor: 4.965

7.  The incidence of bacteraemia associated with tracheal intubation.

Authors:  C Valdés; I Tomás; M Alvarez; J Limeres; J Medina; P Diz
Journal:  Anaesthesia       Date:  2008-06       Impact factor: 6.955

Review 8.  Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America.

Authors:  Naomi P O'Grady; Philip S Barie; John G Bartlett; Thomas Bleck; Karen Carroll; Andre C Kalil; Peter Linden; Dennis G Maki; David Nierman; William Pasculle; Henry Masur
Journal:  Crit Care Med       Date:  2008-04       Impact factor: 7.598

9.  Frequency of bacteremia associated with transesophageal echocardiography in intensive care unit patients: a prospective study of 139 patients.

Authors:  H Mentec; P Vignon; S Terré; B Cholley; E Roupie; P Legrand; F Lemaire; C Brun-Buisson
Journal:  Crit Care Med       Date:  1995-07       Impact factor: 7.598

10.  Intensive care unit acquired infection and organ failure.

Authors:  Pierre Damas; Didier Ledoux; Monique Nys; Mehran Monchi; Patricia Wiesen; Benoît Beauve; Jean-Charles Preiser
Journal:  Intensive Care Med       Date:  2008-02-08       Impact factor: 17.440

View more
  3 in total

1.  Impact of Antibiotic Therapy during Bedside Percutaneous Tracheotomy procedure in an Intensive Care.

Authors:  Evgeni Brotfain; Abraham Borer; Lisa Saidel-Odes; Leonid Koyfman; Amit Frenkel; Alexander Smolikov; Shaun E Gruenbaum; Alexander Zlotnik; Moti Klein
Journal:  J Acute Med       Date:  2017-03-01

2.  The Feasibility of Percutaneous Dilatational Tracheostomy in Immunosuppressed ICU Patients with or without Thrombocytopenia.

Authors:  Marianne Angelberger; Michaela Barnikel; Alessia Fraccaroli; Johanna Tischer; Sofía Antón; Alexandra Pawlikowski; Mark Op den Winkel; Hans Joachim Stemmler; Stephanie-Susanne Stecher
Journal:  Crit Care Res Pract       Date:  2022-05-26

Review 3.  Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-01-08       Impact factor: 17.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.